Ensayos clínicos

Inclusion Criteria:

Subjects must be > 18 years of age who are on ongoing treatment with apixaban with one or more of the following criteria will be included:

• A condition that would require long term anticoagulation with one of the DOAC such as recurrent venous thromboembolic disease or atrial fibrillation plus one of the points below.
  • Recent GI bleeding while on apixaban therapy.
  • Prior history of bleeding with warfarin.

  Exclusion Criteria:

• Pregnant patients
• Renal impairment (GFR less than 50 mg/dl)
• Contraindication for apixaban use
• Mentally incapable of signing a consent form
• Patients with history of valvular heart disease
• Patients with known anti-phospholipid syndrome
• Patients with active malignancy